FERRIC CARBOXYMALTOSE

( DrugBank: Ferric carboxymaltose / KEGG DRUG: Ferric carboxymaltose )

4 diseases

ID	Disease name (Link within this page)	Number of trials
86	Pulmonary arterial hypertension	4
96	Crohn disease	1

ID	Disease name (Link within this page)	Number of trials
97	Ulcerative colitis	1
299	Cystic fibrosis	2

86. Pulmonary arterial hypertension

Clinical trials : 1,205 / Drugs : 684 - (DrugBank : 124) / Drug target genes : 100 - Drug target pathways : 193

trials per page:

Showing 1 to 4 of 4 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-024585-22-DE (EUCTR)	01/12/2016	17/08/2016	What is the effect of intravenous iron supplementation on cardiopulmonary haemodynamics, exercise ca ...	What is the effect of intravenous iron supplementation on cardiopulmonary haemodynamics, exercise ca ...	Idiopathic or familial pulmonary arterial hypertension MedDRA version: 19.0;Level: PT;Classification ...	Trade Name: Ferinject Product Name: Ferinject INN or Proposed INN: FERRIC CARBOXYMALTOSE	Imperial College Academic Healthsciences Centre	NULL	Not Recruiting			Female: yes Male: yes	60	Phase 2	Germany;United Kingdom
2	NCT01847352 (ClinicalTrials.gov)	February 2013	1/5/2013	Iron Status and Hypoxic Pulmonary Vascular Responses	Effect of Endogenous Iron Status on Hypoxic Pulmonary Vascular Responses and Their Attenuation by In ...	Lung Hypoxia;Pulmonary Arterial Hypertension;Iron Deficiency	Drug: Intravenous administration of ferric carboxymaltose;Other: Subacute hypoxic exposures	University of Oxford	National Institute for Health Research, United Kingdom;British Heart Foundation	Completed	18 Years	N/A	Both	31	N/A	United Kingdom
3	EUCTR2010-024585-22-GB (EUCTR)	25/03/2011	25/02/2011	What is the effect of intravenous iron supplementation on cardiopulmonary haemodynamics, exercise ca ...	What is the effect of intravenous iron supplementation on cardiopulmonary haemodynamics, exercise ca ...	Idiopathic or familial pulmonary arterial hypertension MedDRA version: 18.0;Level: PT;Classification ...	Trade Name: Ferinject Product Name: Ferinject INN or Proposed INN: Ferric carboxymaltose	Imperial College Academic Healthsciences Centre	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	Germany;United Kingdom
4	EUCTR2010-023233-30-NL (EUCTR)	13/12/2010	06/10/2010	‘Intravenous iron treatment in iron deficient patients with pulmonary arterialhypertension' - Treati ...	‘Intravenous iron treatment in iron deficient patients with pulmonary arterialhypertension' - Treati ...	Objective: To evaluate the effects of intravenous iron suppletion in iron deficient IPAH patients.St ...	Trade Name: Ferinject Product Name: Ferric carboxymaltose Product Code: RVG 33865	VU university medical center	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	30		Netherlands

First Previous1Next Last

96. Crohn disease

Clinical trials : 2,442 / Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00810030 (ClinicalTrials.gov)	October 2008	16/12/2008	FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR	Select A Multi-centre Randomised Prospective Open-label Study to Investigate the Efficacy & Safety o ...	Inflammatory Bowel Disease;Anemia;Iron Deficiency;Iron-Deficiency Anemia;Crohn's Disease;Ulcerative ...	Drug: Ferric carboxymaltose;Drug: Iron Sucrose	Vifor Inc.	Parexel;ClinStar	Completed	18 Years	N/A	Both	484	Phase 3	Austria;Russian Federation

First Previous1Next Last

97. Ulcerative colitis

Clinical trials : 2,630 / Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00810030 (ClinicalTrials.gov)	October 2008	16/12/2008	FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR	Select A Multi-centre Randomised Prospective Open-label Study to Investigate the Efficacy & Safety o ...	Inflammatory Bowel Disease;Anemia;Iron Deficiency;Iron-Deficiency Anemia;Crohn's Disease;Ulcerative ...	Drug: Ferric carboxymaltose;Drug: Iron Sucrose	Vifor Inc.	Parexel;ClinStar	Completed	18 Years	N/A	Both	484	Phase 3	Austria;Russian Federation

First Previous1Next Last

299. Cystic fibrosis

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03632525 (ClinicalTrials.gov)	February 22, 2019	21/6/2018	Intravenous Iron in Adults With Cystic Fibrosis	A Pilot Trial of Intravenous Iron for the Treatment of Iron Deficiency in Adult Patients With Cystic ...	Cystic Fibrosis;Iron-deficiency	Drug: Ferric carboxymaltose	University of Oxford	NULL	Completed	18 Years	N/A	All	20	Phase 4	United Kingdom
2	EUCTR2018-002366-39-GB (EUCTR)	23/08/2018	20/06/2019	A pilot trial of intravenous iron for the treatment of low iron levels in adult patients with cystic ...	A pilot trial of intravenous iron for the treatment of iron deficiency in adult patients with cystic ...	Cystic fibrosis MedDRA version: 20.0;Level: PT;Classification code 10011762;Term: Cystic fibrosis;Sy ...	Trade Name: Ferinject Product Name: Ferinject INN or Proposed INN: Ferric carboxymaltose	University of Oxford / Clinical Trials and Research Governance	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 4	United Kingdom

First Previous1Next Last